NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

American Eagle

(AEO) - Get Report

upgraded at Sterne Agee to Buy. $27 price target. Estimates also boosted, as new management initiatives should drive growth.

Advanced Micro

(AMD) - Get Report

upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Valuation call, as the stock is down 49% over the past year. $3.50 price target.

Amgen

(AMGN) - Get Report

upgraded at UBS from Neutral to Buy, UBS said. $96 price target. Expect better near-term clinical data.

Ariad Pharmaceuticals

(ARIA)

upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $26 price target. Expect continued strong clinical data in the near term.

Biogen Idec

(BIIB) - Get Report

downgraded at UBS from Buy to Neutral, UBS said. $156 price target. Valuation call, as the stock is up 56% from the last upgrade.

Bemis

(BMS) - Get Report

rated new Neutral at JPMorgan. $37 price target. Lagging fundamentals balance cash generation story.

Brocade Communications Systems

(BRCD)

upgraded to buy at TheStreet Ratings.

Colony Financial

(CLNY) - Get Report

downgraded to hold at TheStreet Ratings.

Celgene

(CELG) - Get Report

downgraded at UBS from Buy to Neutral, UBS said. $80 price target. Valuation call, as the stock is up 27% since Revlimid was not approved in the EU.

Cliffs Natural

(CLF) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. $39 price target. Estimates also cut, given lower expected iron ore prices and rising costs.

Carpenter Technology

(CRS) - Get Report

upgraded at JPMorgan to Overweight from Neutral, JPMorgan said. $70 price target. Sustainable growth in materials.

Dover

(DOV) - Get Report

upgraded at JP Morgan from Underweight to Neutral, JP Morgan said. Valuation call.

Amdocs

(DOX) - Get Report

downgraded at Jefferies to Hold from Buy, Jefferies said. $35 price target. Full valuation.

Exelon

(EXC) - Get Report

downgraded at Citigroup from Neutral to Sell, Citigroup said. $31 price target. Estimates also cut, given higher expected costs.

Fifth Third Bancorp

(FITB) - Get Report

downgraded at Oppenheimer to Perform from Outperform, Oppenheimer said. Catalyst achieved.

Fulton Financial

(FULT) - Get Report

upgraded at Sterne Agee to Buy from Hold, Sterne Agee said. $11.50 price target. Attractive valuation.

Hubbell

(HUB.B)

downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Stock is already factoring in a late-stage economic recovery.

International Paper

(IP) - Get Report

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $39 price target. Stock is already pricing in a potential price hike, which may not yet materialize.

Moody's

(MCO) - Get Report

upgraded at Lazard to Buy from Neutral, Lazard said. $52 price target. Company is leveraged to high debt issuance rates.

Nextera Energy

(NEE) - Get Report

upgraded at Wells from Market Perform to Outperform, Wells Fargo said. Stock is attractive, following the recent rotation out of utility stocks.

NRG Energy

(NRG) - Get Report

upgraded at Goldman from Neutral to Buy, Goldman Sachs said. $25 price target. Texas should drive growth and the company generates solid free cash flow.

Packaging Corp.

(PKG) - Get Report

downgraded at Goldman from Buy to Hold, Goldman Sachs said. $34 price target. Valuation call, as the sector has made a strong move over the past several weeks.

PNC Financial Services Group

(PNC) - Get Report

upgraded at Oppenheimer to Outperform from Perform, Oppenheimer said. $75 price target. Acquisition of RBC Bank (USA) is an ideal platform.

PPG

(PPG) - Get Report

upgraded at Jefferies to Buy from Hold, Jefferies said. $135 price target. Taking the right steps.

Rock-Tenn

(RKT)

downgraded at Deutsche from Buy to Hold, Deutsche Bank said. Valuation call, based on a $75 price target.

Sprint Nextel

(S) - Get Report

upgraded at Nomura from Neutral to Buy, Nomura said. $7 price target. Company is cutting costs and fears of increased competition have been overblown.

Sealed Air

(SEE) - Get Report

rated new Overweight at JPMorgan. $19 price target. Cheap on legacy FCF with upside.

Salix Pharmaceuticals

(SLXP)

rated new Market Perform at Leerink. Uncertainty surrounds Relistor and the company lacks near-term catalysts.

Susquehanna

(SUSQ)

downgraded at Sterne Agee from Buy to Neutral, Sterne Agee said. Valuation call, as the stock is up 31% year-to-date.

Tyco

(TYC)

downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. Valuation call.

STOCK COMMENTS / EPS CHANGES

Air Methods

(AIRM)

target raised at Oppenheimer. Shares of AIRM now seen reaching $130, Oppenheimer said. Bullish following meetings with management. Outperform rating.

Clean Harbors

(CLH) - Get Report

numbers cut at Credit Suisse. Shares of CLH now seen reaching $65. Estimates also reduced, given lower expected oil service margins. Outperform rating.

Endo Pharmaceuticals

(ENDP) - Get Report

added to US 1 List at BofA/Merrill. ENDP was placed on the US 1 list, Bank of America/Merrill Lynch said. Opana ER market share should soon recover. Buy rating and $40 price target.

FMC Corp

(FMC) - Get Report

numbers raised at Jefferies. Shares of FMC now seen reaching $66, Jefferies said. Estimates also raised on greater emphasis on organic growth. Buy rating.

Intel

(INTC) - Get Report

estimates, target reduced at JMP. INTC estimates were cut through 2013, JMP Securities said. Company lowered its guidance. Outperform rating and new $30 price target.

Lululemon

(LULU) - Get Report

estimates, target raised at Nomura. Shares of LULU now seen reaching $62, according to Nomura. Estimates also increased, as the company is realizing a lower tax rate. Neutral rating.

Regions Financial

(RF) - Get Report

added to Conviction Buy List at Goldman. Company can continue to cut costs to right-size the business.

Urban Outfitters

(URBN) - Get Report

added to US 1 List at BofA/Merrill. Comp sales growth should continue to turn around. Buy rating and $45 price target.

Wells Fargo

(WFC) - Get Report

cut from Conviction Buy List at Goldman. Valuation call.

Williams-Sonoma

(WSM) - Get Report

numbers increased at Citi. WSM estimates were raised through 2014, Citigroup said. Expect higher back-to-school sales. Buy rating and new $49 price target.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>A Note From Stephanie Link

>>The Day Ahead: The Fed Is Like an Old Flame

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.